Abstract Purpose of Review The epidemiology of antiphospholipid syndrome (APS) is poorly
understood. Here, we review the current understanding of the epidemiology of …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

Thrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial and/or
small vessel thrombosis in the context of persistently positive antiphospholipid antibodies …

Antiphospholipid syndrome (APS) is a multisystem autoimmune disease most commonly
associated with recurrent arterial and venous thromboembolism and recurrent fetal loss …

Background The optimal strategy for diagnosis and antithrombotic treatment of patients with
antiphospholipid syndrome (APS)–associated acute ischemic stroke (AIS), transient …

Acute myocardial infarction is an important cause of death worldwide. While it often affects
patients of older age, acute myocardial infarction is garnering more attention as a significant …

Background/Aims: Acute myocardial infarction (AMI) occurs when blood supply to the heart
is diminished (ischemia) for long time; ischemia is primarily caused due to hypoxia. The …

Thrombotic manifestations of antiphospholipid syndrome are often a therapeutic dilemma
and challenge. Despite our increasing knowledge of this relatively new disease, many …

Antiphospholipid syndrome (APS) encompasses a wide spectrum of disease manifestations
that may prevail in the form of venous or arterial thrombosis or lead to pregnancy …

Acute myocardial infarction (AMI) represents the acute manifestation of coronary artery
disease. In recent years, microRNAs (miRNAs) have been extensively studied in AMI. This …